OneMedNet flagged for Nasdaq $1 bid-price breach

OneMedNet Corporation reported that Nasdaq has notified the company its common stock no longer meets the $1.00 minimum bid price requirement, after trading below that level for 30 consecutive business days.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

OneMedNet Corporation reported that Nasdaq has notified the company its common stock no longer meets the $1.00 minimum bid price requirement, after trading below that level for 30 consecutive business days. The company has 180 days, until October 12, 2026, to regain compliance by having its share price at or above $1.00 for at least ten consecutive business days. If it still does not comply, OneMedNet may qualify for an additional 180-day period if it meets other Nasdaq Capital Market listing standards and commits to a plan that may include a reverse stock split. The company notes there is no assurance it will regain or maintain compliance, and failure to do so could result in Nasdaq delisting its shares.

Positive

None.

Negative

Nasdaq bid-price deficiency and delisting risk: OneMedNet’s stock has failed to meet Nasdaq’s $1.00 minimum bid price for 30 consecutive business days, triggering a formal deficiency notice and creating a clear risk of delisting if compliance is not regained within the allowed grace periods.

Insights

Nasdaq bid-price noncompliance raises delisting risk for OneMedNet.

OneMedNet has fallen out of compliance with Nasdaq’s $1.00 minimum bid price rule after 30 consecutive trading days below that threshold. It now has October 12, 2026 to lift its share price back to at least $1.00 for ten straight business days.

If the company meets other Nasdaq Capital Market criteria, it may receive a second 180-day compliance period. The text explicitly highlights a potential reverse stock split as a tool to increase the share price, a common mechanical step rather than a change in fundamentals.

The disclosure warns there is no assurance of regaining compliance, and that failure on any Nasdaq listing rule could lead to delisting. Future company actions—such as a formal decision on a reverse split—will determine whether it can maintain its exchange listing over the disclosed compliance windows.

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.

Key Figures

Minimum bid price requirement: $1.00 per share Noncompliance trigger period: 30 consecutive business days Initial compliance period: 180 calendar days +4 more

7 metrics

Minimum bid price requirement $1.00 per share Nasdaq Listing Rule 5550(a)(2) minimum for continued listing

Noncompliance trigger period 30 consecutive business days Closing bid price below $1.00 leading to Nasdaq notice

Initial compliance period 180 calendar days Time until October 12, 2026 to regain bid-price compliance

Required compliant trading window 10 consecutive business days Days stock must close at or above $1.00 to regain compliance

Potential additional period 180 calendar days Possible second compliance window if other standards are met

Warrant exercise price $11.50 per share Redeemable warrants exercisable for one share of common stock

Common stock par value $0.0001 per share Par value of OneMedNet’s common stock

Key Terms

Bid Price Rule, Nasdaq Capital Market, reverse stock split, emerging growth company, +1 more

5 terms

Bid Price Rule regulatory

"not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”)."

Nasdaq Capital Market market

"for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2)"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

reverse stock split financial

"by effecting a reverse stock split, if necessary. If the Company meets these requirements"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

emerging growth company regulatory

"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

market value of publicly held shares financial

"required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards"

The market value of publicly held shares is the total dollar worth of a company’s shares that are available to outside investors, calculated by multiplying the current market price by the number of shares held by the public (the “float”). It matters because it tells investors how much of the company is actually tradable and how the market is pricing that tradable portion—like a price tag on the items on a store shelf, it affects liquidity, volatility and how easy it is to buy or sell a meaningful stake.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Nasdaq notice did OneMedNet (ONMD) receive about its stock?

Nasdaq staff notified OneMedNet that its common stock no longer satisfies the $1.00 minimum bid price requirement, after 30 consecutive business days below that level, placing the company in formal bid-price noncompliance status on The Nasdaq Capital Market.

How long does OneMedNet (ONMD) have to regain Nasdaq bid-price compliance?

OneMedNet has 180 calendar days, until October 12, 2026, to regain compliance. Its common stock must trade at or above a $1.00 minimum bid price for at least ten consecutive business days within this initial grace period to satisfy Nasdaq Listing Rule 5550(a)(2).

Can OneMedNet (ONMD) receive more time beyond October 12, 2026?

The company may receive an additional 180-day period if it satisfies all initial Nasdaq Capital Market listing standards except bid price and notifies Nasdaq of its intent to cure, potentially including a reverse stock split, subject to Nasdaq staff determining eligibility for this second phase.

What options is OneMedNet (ONMD) considering to address the Nasdaq deficiency?

OneMedNet states it will monitor its share price and may consider available options to regain compliance with the Bid Price Rule. These options may include implementing a reverse stock split to increase the per-share trading price if the board deems such action appropriate.

What happens if OneMedNet (ONMD) cannot regain Nasdaq compliance?

If OneMedNet fails to regain compliance within the permitted periods, Nasdaq staff may move to delist its securities. The company acknowledges there is no assurance it will satisfy the Bid Price Rule or other Nasdaq listing standards, and noncompliance could result in removal from the exchange.

What is Nasdaq’s Bid Price Rule affecting OneMedNet (ONMD)?

Nasdaq Listing Rule 5550(a)(2), called the Bid Price Rule, requires a minimum $1.00 bid price for continued listing on the Nasdaq Capital Market. OneMedNet became noncompliant after its stock’s closing bid price remained below $1.00 for 30 straight business days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/20/2026 - 05:15 PM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): April 14, 2026

ONEMEDNET CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

001-40386

86-2076743

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

6385 Old Shady Oak Road, Suite 250

Eden Prairie, MN 55344

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: 800-918-7189

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

	☐	Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 par value per share	ONMD	The Nasdaq Stock Market LLC

Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share	ONMDW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On April 14, 2026, OneMedNet Corporation (the “Company”) received notice (the “Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”).

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until October 12, 2026, to regain compliance with the Bid Price Rule. To regain compliance, the minimum bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this 180-calendar day grace period. In the event the Company does not regain compliance with the Bid Price Rule by October 12, 2026, the Company may be eligible for an additional 180-calendar day compliance period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, the Staff will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, the Staff will provide notice that its securities will be subject to delisting

The Company intends to continue to actively monitor the bid price of its common stock and may, if appropriate, consider implementing available options to regain compliance with the Bid Price Rule, which options may include effecting a reverse stock split, if necessary, to attempt to regain compliance. There can be no assurance that the Company will be able to regain compliance with the Bid Price Rule or will otherwise be in compliance with other Nasdaq Listing Rules. The Company’s failure to regain compliance with any Nasdaq Listing Rule could result in delisting.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 20, 2026

	ONEMEDNET CORPORATION

	By:	/s/ Aaron Green
		Aaron Green
		Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

OneMedNet flagged for Nasdaq $1 bid-price breach